☰

Angel Pazos - Publications

Affiliations: 
Universidad de Cantabria, Spain, Santander, Cantabria, Spain 
Area:
Receptors for Neurotransmitters
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

145 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Breviario S, Senserrich J, Florensa-Zanuy E, Garro-Martínez E, Díaz Á, Castro E, Pazos Á, Pilar-Cuéllar F. Brain matrix metalloproteinase-9 activity is altered in the corticosterone mouse model of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 120: 110624. PMID 36038021 DOI: 10.1016/j.pnpbp.2022.110624  0.439
2021 Garro-Martínez E, Fullana MN, Florensa-Zanuy E, Senserrich J, Paz V, Ruiz-Bronchal E, Adell A, Castro E, Díaz Á, Pazos Á, Bortolozzi A, Pilar-Cuéllar F. mTOR Knockdown in the Infralimbic Cortex Evokes A Depressive-like State in Mouse. International Journal of Molecular Sciences. 22. PMID 34445375 DOI: 10.3390/ijms22168671  0.457
2021 Amigo J, Garro-Martinez E, Vidal Casado R, Compan V, Pilar-Cuéllar F, Pazos A, Díaz A, Castro E. 5-HT Receptors Are Not Involved in the Effects of Fluoxetine in the Corticosterone Model of Depression. Acs Chemical Neuroscience. PMID 33974408 DOI: 10.1021/acschemneuro.1c00158  0.5
2021 Florensa-Zanuy E, Garro-Martínez E, Adell A, Castro E, Díaz Á, Pazos Á, Mac-Dowell KS, Martín-Hernández D, Pilar-Cuéllar F. Cannabidiol antidepressant-like effect in the lipopolysaccharide model in mice: modulation of inflammatory pathways. Biochemical Pharmacology. 114433. PMID 33513342 DOI: 10.1016/j.bcp.2021.114433  0.461
2019 Garro-Martínez E, Vidal R, Adell A, Díaz Á, Castro E, Amigó J, Gutiérrez-Lanza R, Florensa-Zanuy E, Gómez-Acero L, Taketo MM, Pazos Á, Pilar-Cuéllar F. β-Catenin Role in the Vulnerability/Resilience to Stress-Related Disorders Is Associated to Changes in the Serotonergic System. Molecular Neurobiology. PMID 31823197 DOI: 10.1007/s12035-019-01841-0  0.543
2019 Pilar-Cuellar F, Castro E, Bretin S, Mocaer E, Pazos Á, Díaz Á. S 47445 counteracts the behavioral manifestations and hippocampal neuroplasticity changes in bulbectomized mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 30980840 DOI: 10.1016/j.pnpbp.2019.04.005  0.537
2018 Mato S, Pilar-Cuéllar F, Valdizán EM, González-Maeso J, Rodríguez-Puertas R, Meana J, Sallés J, Crespo-Facorro B, Pazos Á. Selective up-regulation of cannabinoid CB receptor coupling to Go-proteins in suicide victims with mood disorders. Biochemical Pharmacology. PMID 30099006 DOI: 10.1016/J.Bcp.2018.08.012  0.805
2018 Ibarra-Lecue I, Pilar-Cuéllar F, Muguruza C, Florensa-Zanuy E, Díaz Á, Urigüen L, Castro E, Pazos A, Callado LF. The endocannabinoid system in mental disorders: Evidence from human brain studies. Biochemical Pharmacology. PMID 30026022 DOI: 10.1016/j.bcp.2018.07.009  0.531
2018 Vidal R, Garro-Martínez E, Díaz Á, Castro E, Florensa-Zanuy E, Taketo MM, Pazos Á, Pilar-Cuéllar F. Targeting β-Catenin in GLAST-Expressing Cells: Impact on Anxiety and Depression-Related Behavior and Hippocampal Proliferation. Molecular Neurobiology. PMID 29737454 DOI: 10.1007/s12035-018-1100-2  0.479
2017 Pilar-Cuellar F, Vidal Casado R, Diaz A, Garro-Martinez E, Linge R, Castro E, Haberzettl R, Fink H, Bert B, Brosda J, Romero B, Crespo Facorro B, Pazos A. Enhanced stress response in 5-HT1AR overexpressing mice: altered HPA function and hippocampal long-term potentiation. Acs Chemical Neuroscience. PMID 28777913 DOI: 10.1021/acschemneuro.7b00156  0.504
2017 Palacios JM, Pazos A, Hoyer D. A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment. Psychopharmacology. PMID 28265714 DOI: 10.1007/S00213-017-4545-5  0.601
2016 Fernández-Pastor B, Ortega JE, Grandoso L, Castro E, Ugedo L, Pazos Á, Meana JJ. Chronic citalopram administration desensitizes prefrontal cortex but not somatodendritic α2-adrenoceptors in rat brain. Neuropharmacology. PMID 27908769 DOI: 10.1016/j.neuropharm.2016.11.025  0.321
2016 Amigó J, Díaz A, Pilar-Cuéllar F, Vidal R, Martín A, Compan V, Pazos A, Castro E. The absence of 5-HT4 receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: Adaptive changes in hippocampal neuroplasticity markers and 5-HT1A autoreceptor. Neuropharmacology. PMID 27586007 DOI: 10.1016/J.Neuropharm.2016.08.037  0.328
2016 España-Serrano L, Guerra Martín-Palanco N, Montero-Pedrazuela A, Pérez-Santamarina E, Vidal R, García-Consuegra I, Valdizán EM, Pazos A, Palomo T, Jiménez-Arriero MÁ, Guadaño-Ferraz A, Hoenicka J. The Addiction-Related Protein ANKK1 is Differentially Expressed During the Cell Cycle in Neural Precursors. Cerebral Cortex (New York, N.Y. : 1991). PMID 27166167 DOI: 10.1093/cercor/bhw129  0.352
2016 Jiménez-Sánchez L, Linge R, Campa L, Valdizán EM, Pazos Á, Díaz Á, Adell A. Behavioral, neurochemical and molecular changes after acute deep brain stimulation of the infralimbic prefrontal cortex. Neuropharmacology. PMID 27108934 DOI: 10.1016/j.neuropharm.2016.04.020  0.546
2015 Linge R, Jiménez-Sánchez L, Campa L, Pilar-Cuéllar F, Vidal R, Pazos A, Adell A, Díaz Á. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors. Neuropharmacology. 103: 16-26. PMID 26711860 DOI: 10.1016/j.neuropharm.2015.12.017  0.592
2015 Ferrés-Coy A, Galofré M, Pilar-Cuéllar F, Vidal R, Paz V, Ruiz-Bronchal E, Campa L, Pazos Á, Caso JR, Leza JC, Alvarado G, Montefeltro A, Valdizán EM, Artigas F, Bortolozzi A. Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration. Molecular Psychiatry. PMID 26100539 DOI: 10.1038/mp.2015.80  0.315
2014 Barreda-Gómez G, Giralt MT, Pazos A, Rodríguez-Puertas R. Galanin activated Gi/o-proteins in human and rat central nervous systems. Neuropeptides. 48: 295-304. PMID 25043784 DOI: 10.1016/j.npep.2014.06.002  0.739
2014 Rodríguez-Gaztelumendi A, Rojo ML, Pazos A, Díaz A. An altered spinal serotonergic system contributes to increased thermal nociception in an animal model of depression. Experimental Brain Research. 232: 1793-803. PMID 24584836 DOI: 10.1007/s00221-014-3871-7  0.393
2014 Vidal R, Castro E, Pilar-Cuéllar F, Pascual-Brazo J, Díaz A, Rojo ML, Linge R, Martín A, Valdizán EM, Pazos A. Serotonin 5-HT4 receptors: A new strategy for developing fast acting antidepressants? Current Pharmaceutical Design. 20: 3751-62. PMID 24180399 DOI: 10.2174/13816128113196660734  0.455
2013 Pilar-Cuéllar F, Vidal R, Díaz A, Castro E, dos Anjos S, Pascual-Brazo J, Linge R, Vargas V, Blanco H, Martínez-Villayandre B, Pazos Á, Valdizán EM. Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication. Neural Plasticity. 2013: 537265. PMID 23862076 DOI: 10.1155/2013/537265  0.332
2013 Vidal R, Diaz A, Pazos A, Castro E. Region-specific regulation of 5-HT1B receptors in the rat brain by chronic venlafaxine treatment. Psychopharmacology. 229: 177-85. PMID 23609771 DOI: 10.1007/s00213-013-3104-y  0.62
2013 Pazos MR, Mohammed N, Lafuente H, Santos M, Martínez-Pinilla E, Moreno E, Valdizan E, Romero J, Pazos A, Franco R, Hillard CJ, Alvarez FJ, Martínez-Orgado J. Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors. Neuropharmacology. 71: 282-91. PMID 23587650 DOI: 10.1016/j.neuropharm.2013.03.027  0.45
2013 Martínez-Cué C, Martínez P, Rueda N, Vidal R, García S, Vidal V, Corrales A, Montero JA, Pazos Á, Flórez J, Gasser R, Thomas AW, Honer M, Knoflach F, Trejo JL, et al. Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 3953-66. PMID 23447605 DOI: 10.1523/Jneurosci.1203-12.2013  0.312
2013 Urigüen L, Gil-Pisa I, Munarriz-Cuezva E, Berrocoso E, Pascau J, Soto-Montenegro ML, Gutiérrez-Adán A, Pintado B, Madrigal JL, Castro E, Sánchez-Blázquez P, Ortega JE, Guerrero MJ, Ferrer-Alcon M, García-Sevilla JA, ... ... Pazos A, et al. Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia. Translational Psychiatry. 3: e221. PMID 23340504 DOI: 10.1038/Tp.2012.149  0.357
2013 Ferrés-Coy A, Pilar-Cuellar F, Vidal R, Paz V, Masana M, Cortés R, Carmona MC, Campa L, Pazos A, Montefeltro A, Valdizán EM, Artigas F, Bortolozzi A. RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis. Translational Psychiatry. 3: e211. PMID 23321808 DOI: 10.1038/tp.2012.135  0.351
2013 Linge R, Pazos A, Diaz A. P.1.013 Chronic (−)cannabidiol produces antidepressant-like effects in bulbectomised mice, acting on 5-HT1A and CB1 receptor functionality European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70015-4  0.354
2012 Rojo ML, Rodríguez-Gaztelumendi A, Pazos Á, Díaz Á. Differential adaptive changes on serotonin and noradrenaline transporters in a rat model of peripheral neuropathic pain. Neuroscience Letters. 515: 181-6. PMID 22480692 DOI: 10.1016/j.neulet.2012.03.050  0.32
2012 Pascual-Brazo J, Castro E, Díaz A, Valdizán EM, Pilar-Cuéllar F, Vidal R, Treceño B, Pazos A. Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HTâ‚„ receptor agonist RS67333. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 631-43. PMID 21733238 DOI: 10.1017/S1461145711000782  0.398
2012 Pilar-Cuéllar F, Vidal R, Pazos A. Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects. British Journal of Pharmacology. 165: 1046-57. PMID 21627639 DOI: 10.1111/j.1476-5381.2011.01516.x  0.438
2011 Vidal R, Pilar-Cuéllar F, dos Anjos S, Linge R, Treceño B, Vargas VI, Rodriguez-Gaztelumendi A, Mostany R, Castro E, Diaz A, Valdizán EM, Pazos A. New strategies in the development of antidepressants: towards the modulation of neuroplasticity pathways. Current Pharmaceutical Design. 17: 521-33. PMID 21375480 DOI: 10.2174/138161211795164086  0.72
2010 Vidal R, Valdizan EM, Vilaró MT, Pazos A, Castro E. Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats. British Journal of Pharmacology. 161: 695-706. PMID 20880406 DOI: 10.1111/j.1476-5381.2010.00903.x  0.425
2010 Valdizán EM, Díez-Alarcia R, González-Maeso J, Pilar-Cuéllar F, García-Sevilla JA, Meana JJ, Pazos A. α₂-Adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims. Biological Psychiatry. 68: 869-72. PMID 20864091 DOI: 10.1016/J.Biopsych.2010.07.023  0.364
2010 Mato S, Vidal R, Castro E, Díaz A, Pazos A, Valdizán EM. Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine 1A receptor-dependent mechanisms. Molecular Pharmacology. 77: 424-34. PMID 19995940 DOI: 10.1124/Mol.109.060079  0.721
2010 Valdizán EM, Castro E, Pazos A. Agonist-dependent modulation of G-protein coupling and transduction of 5-HT1A receptors in rat dorsal raphe nucleus. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 835-43. PMID 19895724 DOI: 10.1017/S1461145709990940  0.37
2009 Vidal R, Valdizán EM, Mostany R, Pazos A, Castro E. Long-term treatment with fluoxetine induces desensitization of 5-HT4 receptor-dependent signalling and functionality in rat brain. Journal of Neurochemistry. 110: 1120-7. PMID 19522734 DOI: 10.1111/j.1471-4159.2009.06210.x  0.736
2009 Rodríguez-Gaztelumendi A, Rojo ML, Pazos A, Díaz A. Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine. Journal of Neurochemistry. 108: 1423-33. PMID 19183263 DOI: 10.1111/j.1471-4159.2009.05898.x  0.422
2008 Castro E, Díaz A, Rodriguez-Gaztelumendi A, Del Olmo E, Pazos A. WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality. Neuropharmacology. 55: 1391-6. PMID 18809415 DOI: 10.1016/j.neuropharm.2008.08.038  0.711
2008 Sáiz J, Pazos A, Del Olmo E, Sáiz V, Sánchez A. Yohimbine-induced alterations in alpha(2)-adrenoceptors in kidney regions of the spontaneously hypertensive rats: an autoradiographic analysis. Pharmacological Reports : Pr. 60: 391-8. PMID 18622064  0.579
2008 Mostany R, Valdizán EM, Pazos A. A role for nuclear beta-catenin in SNRI antidepressant-induced hippocampal cell proliferation. Neuropharmacology. 55: 18-26. PMID 18511088 DOI: 10.1016/j.neuropharm.2008.04.012  0.671
2007 Mato S, Aso E, Castro E, Martín M, Valverde O, Maldonado R, Pazos A. CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors. Journal of Neurochemistry. 103: 2111-20. PMID 17944876 DOI: 10.1111/J.1471-4159.2007.04961.X  0.68
2006 Zazpe A, Artaiz I, Innerárity A, Del Olmo E, Castro E, Labeaga L, Pazos A, Orjales A. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties. Neuropharmacology. 51: 129-40. PMID 16643965 DOI: 10.1016/j.neuropharm.2006.03.008  0.635
2006 Alonso-Ferrero ME, Paniagua MA, Mostany R, Pilar-Cuéllar F, Díez-Alarcia R, Pazos A, Fernández-López A. Cannabinoid system in the budgerigar brain. Brain Research. 1087: 105-13. PMID 16626655 DOI: 10.1016/j.brainres.2006.02.119  0.76
2006 Ruiz de Azúa I, del Olmo E, Pazos A, Sallés J. Transmembrane signaling through phospholipase C-beta in the developing human prefrontal cortex. Journal of Neuroscience Research. 84: 13-26. PMID 16615043 DOI: 10.1002/jnr.20858  0.659
2006 Valverde O, Aso E, Ozaita A, Valdizán E, Pazos A, Maldonado R. P.2.b.002 Depressive-like phenotype in mice lacking cannabinoid CB1 receptors European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)70316-9  0.335
2005 Artaiz I, Zazpe A, Innerárity A, Del Olmo E, Díaz A, Ruiz-Ortega JA, Castro E, Pena R, Labeaga L, Pazos A, Orjales A. Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties. Psychopharmacology. 182: 400-13. PMID 16032410 DOI: 10.1007/s00213-005-0087-3  0.777
2005 Rueda N, Mostany R, Pazos A, Flórez J, Martínez-Cué C. Cell proliferation is reduced in the dentate gyrus of aged but not young Ts65Dn mice, a model of Down syndrome. Neuroscience Letters. 380: 197-201. PMID 15854777 DOI: 10.1016/J.Neulet.2005.01.039  0.64
2005 Mostany R, Pazos A, Castro ME. Autoradiographic characterisation of [35S]GTPgammaS binding stimulation mediated by 5-HT1B receptor in postmortem human brain. Neuropharmacology. 48: 25-33. PMID 15617724 DOI: 10.1016/j.neuropharm.2004.08.013  0.744
2004 Mato S, Chevaleyre V, Robbe D, Pazos A, Castillo PE, Manzoni OJ. A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity. Nature Neuroscience. 7: 585-6. PMID 15146190 DOI: 10.1038/Nn1251  0.735
2004 Mato S, Pazos A. Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain. Neuropharmacology. 46: 716-26. PMID 14996549 DOI: 10.1016/J.Neuropharm.2003.11.004  0.704
2004 Martín-Cora FJ, Pazos A. Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species. British Journal of Pharmacology. 141: 92-104. PMID 14656806 DOI: 10.1038/sj.bjp.0705576  0.5
2003 Valdizán EM, Gutierrez O, Pazos A. Adenylate cyclase activity in postmortem brain of suicide subjects: reduced response to beta-adrenergic stimulation. Biological Psychiatry. 54: 1457-64. PMID 14675811 DOI: 10.1016/S0006-3223(03)00589-4  0.348
2003 Mato S, Del Olmo E, Pazos A. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. The European Journal of Neuroscience. 17: 1747-54. PMID 12752773 DOI: 10.1046/J.1460-9568.2003.02599.X  0.779
2003 Castro M, Diaz A, del Olmo E, Pazos A. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology. 44: 93-101. PMID 12559126 DOI: 10.1016/S0028-3908(02)00340-4  0.726
2002 Tomiyama M, Rodríguez-Puertas R, Cortés R, Pazos A, Palacios JM, Mengod G. Flip and flop splice variants of AMPA receptor subunits in the spinal cord of amyotrophic lateral sclerosis. Synapse (New York, N.Y.). 45: 245-9. PMID 12125045 DOI: 10.1002/syn.10098  0.425
2002 Mato S, Pazos A, Valdizán EM. Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain. European Journal of Pharmacology. 443: 43-6. PMID 12044790 DOI: 10.1016/S0014-2999(02)01575-3  0.71
2002 Díaz A, Pazos A, Flórez J, Ayesta FJ, Santana V, Hurlé MA. Regulation of mu-opioid receptors, G-protein-coupled receptor kinases and beta-arrestin 2 in the rat brain after chronic opioid receptor antagonism. Neuroscience. 112: 345-53. PMID 12044452 DOI: 10.1016/S0306-4522(02)00073-8  0.423
2001 del Olmo E, Pazos A. Aminergic receptors during the development of the human brain: the contribution of in vitro imaging techniques. Journal of Chemical Neuroanatomy. 22: 101-14. PMID 11470558 DOI: 10.1016/S0891-0618(01)00097-7  0.702
2000 Díaz A, Pazos A, Flórez J, Hurlé MA. Autoradiographic mapping of mu-opioid receptors during opiate tolerance and supersensitivity in the rat central nervous system. Naunyn-Schmiedeberg's Archives of Pharmacology. 362: 101-9. PMID 10961371 DOI: 10.1007/S002100000258  0.384
2000 Castro ME, Harrison PJ, Pazos A, Sharp T. Affinity of (+/-)-pindolol, (-)-penbutolol, and (-)-tertatolol for pre- and postsynaptic serotonin 5-HT(1A) receptors in human and rat brain. Journal of Neurochemistry. 75: 755-62. PMID 10899952 DOI: 10.1046/J.1471-4159.2000.0750755.X  0.355
2000 Díaz A, Flórez J, Pazos A, Hurlé MA. Opioid tolerance and supersensitivity induce regional changes in the autoradiographic density of dihydropyridine-sensitive calcium channels in the rat central nervous system. Pain. 86: 227-35. PMID 10812252 DOI: 10.1016/S0304-3959(00)00249-9  0.339
2000 Rodríguez-Puertas R, González-Maeso J, Meana JJ, Pazos A. Autoradiography of receptor-activated G-proteins in post mortem human brain. Neuroscience. 96: 169-80. PMID 10683421 DOI: 10.1016/S0306-4522(99)00527-8  0.524
2000 González AM, Berciano J, Figols J, Pazos A, Pascual J. Loss of dopamine uptake sites and dopamine D2 receptors in striatonigral degeneration. Brain Research. 852: 228-32. PMID 10661519 DOI: 10.1016/S0006-8993(99)02205-2  0.606
2000 Sanchez MD, Milanés MV, Pazos A, Diaz A, Laorden ML. Autoradiographic evidence of delta-opioid receptor downregulation after prenatal stress in offspring rat brain. Pharmacology. 60: 13-8. PMID 10629438  0.499
1998 Pazos A, Castro ME, del Olmo E, Romón T, del Arco C. Autoradiographic characterization, anatomical distribution, and developmental pattern of a new 5-HT site in human brain. Annals of the New York Academy of Sciences. 861: 262. PMID 9928279 DOI: 10.1111/j.1749-6632.1998.tb10213.x  0.646
1998 del Olmo E, López-Giménez JF, Vilaró MT, Mengod G, Palacios JM, Pazos A. Early localization of mRNA coding for 5-HT1A receptors in human brain during development. Brain Research. Molecular Brain Research. 60: 123-6. PMID 9748536 DOI: 10.1016/S0169-328X(98)00149-1  0.726
1998 Castro ME, Pascual J, Romón T, Berciano J, Figols J, Pazos A. 5-HT1B receptor binding in degenerative movement disorders. Brain Research. 790: 323-8. PMID 9593971 DOI: 10.1016/S0006-8993(97)01566-7  0.622
1998 Callado LF, Meana JJ, Grijalba B, Pazos A, Sastre M, García-Sevilla JA. Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims. Journal of Neurochemistry. 70: 1114-23. PMID 9489732 DOI: 10.1046/J.1471-4159.1998.70031114.X  0.786
1997 Lahmame A, del Arco C, Pazos A, Yritia M, Armario A. Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants? European Journal of Pharmacology. 337: 115-23. PMID 9430405 DOI: 10.1016/S0014-2999(97)01276-4  0.362
1997 Pascual J, Castro ME, Pazos A. Central sites of actions of zolmitriptan and sumatriptan: 5HT1B, 5HT1D and 5HT1F receptor distribution. Cephalalgia : An International Journal of Headache. 17: 711. PMID 9350394 DOI: 10.1046/J.1468-2982.1997.1706711.X  0.541
1997 Castro ME, Romón T, Castillo MJ, del Olmo E, Pazos A, del Arco C. Identification and characterization of a new serotonergic recognition site with high affinity for 5-carboxamidotryptamine in mammalian brain. Journal of Neurochemistry. 69: 2123-31. PMID 9349558 DOI: 10.1046/J.1471-4159.1997.69052123.X  0.7
1997 Castro ME, Pascual J, Romón T, del Arco C, del Olmo E, Pazos A. Differential distribution of [3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F receptors) in human brain: focus on brainstem and spinal cord. Neuropharmacology. 36: 535-42. PMID 9225278 DOI: 10.1016/S0028-3908(97)00061-0  0.734
1997 Rodríguez-Puertas R, Pascual J, Vilaró T, Pazos A. Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease. Synapse (New York, N.Y.). 26: 341-50. PMID 9215593 DOI: 10.1002/(Sici)1098-2396(199708)26:4<341::Aid-Syn2>3.0.Co;2-6  0.529
1997 Fernández-López A, Revilla V, Candelas MA, González-Gil J, Díaz A, Pazos A. A comparative study of alpha2- and beta-adrenoceptor distribution in pigeon and chick brain. The European Journal of Neuroscience. 9: 871-83. PMID 9182940 DOI: 10.1111/J.1460-9568.1997.Tb01438.X  0.418
1997 Rodríguez-Puertas R, Nilsson S, Pascual J, Pazos A, Hökfelt T. 125I-galanin binding sites in Alzheimer's disease: increases in hippocampal subfields and a decrease in the caudate nucleus. Journal of Neurochemistry. 68: 1106-13. PMID 9048756 DOI: 10.1046/J.1471-4159.1997.68031106.X  0.534
1996 Tomiyama M, Rodriguez-Puertas R, Cortés R, Christnacher A, Sommer B, Pazos A, Palacios JM, Mengod G. Differential regional distribution of AMPA receptor subunit messenger RNAs in the human spinal cord as visualized by in situ hybridization. Neuroscience. 75: 901-15. PMID 8951883 DOI: 10.1016/0306-4522(96)00321-1  0.769
1996 Meana JJ, Callado LF, Pazos A, Grijalba B, García-Sevilla JA. The subtype-selective alpha 2-adrenoceptor antagonists BRL 44408 and ARC 239 also recognize 5-HT1A receptors in the rat brain. European Journal of Pharmacology. 312: 385-8. PMID 8894622 DOI: 10.1016/0014-2999(96)00598-5  0.808
1996 Grijalba B, Callado LF, Javier Meana J, García-Sevilla JA, Pazos A. Alpha 2-adrenoceptor subtypes in the human brain: a pharmacological delineation of [3H]RX-821002 binding to membranes and tissue sections. European Journal of Pharmacology. 310: 83-93. PMID 8880071 DOI: 10.1016/0014-2999(96)00381-0  0.789
1996 Pascual J, del Arco C, Romón T, del Olmo E, Castro E, Pazos A. Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain. Cephalalgia : An International Journal of Headache. 16: 317-22. PMID 8869766 DOI: 10.1046/J.1468-2982.1996.1605317.X  0.741
1996 RodÅ•iguez-Puertas R, Pascual J, Pazos A. Effects of freezing storage time on the density of muscarinic receptors in the human postmortem brain: an autoradiographic study in control and Alzheimer's disease brain tissues. Brain Research. 728: 65-71. PMID 8864298 DOI: 10.1016/0006-8993(96)00385-X  0.57
1996 Sanchez MD, Milanés MV, Pazos A, Diaz A, Laorden ML. Autoradiographic evidence of mu-opioid receptors down-regulation after prenatal stress in offspring rat brain. Brain Research. Developmental Brain Research. 94: 14-21. PMID 8816272 DOI: 10.1016/0165-3806(96)00032-6  0.568
1996 Pascual J, Del Arco C, Romón T, Del Olmo E, Pazos A. [3H]Sumatriptan binding sites in human brain: regional-dependent labelling of 5-HT1D and 5-HT1F receptors. European Journal of Pharmacology. 295: 271-4. PMID 8720594 DOI: 10.1016/0014-2999(95)00748-2  0.736
1996 del Olmo E, del Arco C, Díaz A, Pascual J, Mengod G, Palacios JM, Pazos A. Ontogenetic development of 5-HT1D receptors in human brain: an autoradiographic study. The European Journal of Neuroscience. 8: 53-60. PMID 8713449 DOI: 10.1111/J.1460-9568.1996.Tb01166.X  0.785
1995 Diaz A, Ruiz F, Flórez J, Hurlé MA, Pazos A. Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system. The Journal of Pharmacology and Experimental Therapeutics. 274: 1545-51. PMID 7562532  0.49
1995 Arco CD, Olmo Ed, Rodriguez-Puertas R, Pazos A. Effects of chronic administration of antidepressants on brain 5-HT1 receptor subtypes: Evidence for species differences Pharmacological Research. 31: 187. DOI: 10.1016/1043-6618(95)87006-7  0.444
1994 del Olmo E, Díaz A, Guirao-Piñeyro M, del Arco C, Pascual J, Pazos A. Transient localization of 5-HT1A receptors in human cerebellum during development. Neuroscience Letters. 166: 149-52. PMID 8177491 DOI: 10.1016/0304-3940(94)90472-3  0.734
1994 Rodríguez-Puertas R, Pazos A, Pascual J. Cholinergic markers in degenerative parkinsonism: autoradiographic demonstration of high-affinity choline uptake carrier hyperactivity. Brain Research. 636: 327-32. PMID 8012816 DOI: 10.1016/0006-8993(94)91032-4  0.614
1994 Pascual J, Figols J, Grijalba B, González AM, del Olmo E, Berciano J, Pazos A. Changes in aminergic receptors in a PSP postmortem brain: correlation with pathological findings. Journal of Neural Transmission. Supplementum. 42: 247-60. PMID 7964690 DOI: 10.1007/978-3-7091-6641-3_19  0.816
1994 Gonzalez AM, Walther D, Pazos A, Uhl GR. Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile. Brain Research. Molecular Brain Research. 22: 219-26. PMID 7912402 DOI: 10.1016/0169-328X(94)90050-7  0.481
1994 González AM, Pascual J, Meana JJ, Barturen F, del Arco C, Pazos A, García-Sevilla JA. Autoradiographic demonstration of increased alpha 2-adrenoceptor agonist binding sites in the hippocampus and frontal cortex of depressed suicide victims. Journal of Neurochemistry. 63: 256-65. PMID 7911511 DOI: 10.1046/J.1471-4159.1994.63010256.X  0.616
1994 Grijalba B, Berciano J, Anciones B, Pazos A, Pascual J. Adrenergic receptors in the cerebellum of olivopontocerebellar atrophy. Journal of Neural Transmission. General Section. 96: 135-42. PMID 7857596 DOI: 10.1007/Bf01277935  0.797
1994 Fernández-López A, Revilla V, Candelas MA, Aller MI, Soria C, Pazos A. Identification of beta-adrenoceptors in rat lymph nodes and spleen: an autoradiographic study. European Journal of Pharmacology. 262: 283-6. PMID 7813593 DOI: 10.1016/0014-2999(94)90742-0  0.326
1994 Hurlé M, Díaz A, Ruiz F, Flórez J, Pazos A. Functional and biochemical interactions between the calcium antagonist nimodipine and sufentanil Regulatory Peptides. 53: S17-S18. DOI: 10.1016/0167-0115(94)90219-4  0.54
1993 del Arco C, Galende I, Pazos A. Autoradiographic mapping of 5-HT1 receptors in the guinea-pig brain with particular reference to the 5-HT1D receptor sites. Naunyn-Schmiedeberg's Archives of Pharmacology. 347: 248-56. PMID 8479545 DOI: 10.1007/BF00167442  0.499
1993 Pascual J, Berciano J, González AM, Grijalba B, Figols J, Pazos A. Autoradiographic demonstration of loss of alpha 2-adrenoceptors in progressive supranuclear palsy: preliminary report. Journal of the Neurological Sciences. 114: 165-9. PMID 8095296 DOI: 10.1016/0022-510X(93)90293-8  0.811
1993 Solà C, Martínez E, Camón L, Pazos A, Rodríguez-Farré E. Lindane administration to the rat induces modifications in the regional cerebral binding of [3H]Muscimol, [3H]-flunitrazepam, and t-[35S]butylbicyclophosphorothionate: an autoradiographic study. Journal of Neurochemistry. 60: 1821-34. PMID 7682602 DOI: 10.1111/J.1471-4159.1993.Tb13409.X  0.428
1992 González AM, Pazos A. Affinity changes in muscarinic acetylcholine receptors in the rat brain following acute immobilization stress: an autoradiographic study. European Journal of Pharmacology. 214: 261-8. PMID 1516642 DOI: 10.1016/0014-2999(92)90127-P  0.603
1992 González AM, Pazos A. Modification of muscarinic acetylcholine receptors in the rat brain following chronic immobilization stress: an autoradiographic study. European Journal of Pharmacology. 223: 25-31. PMID 1478257 DOI: 10.1016/0014-2999(92)90814-K  0.578
1992 Pascual J, Berciano J, Grijalba B, del Olmo E, González AM, Figols J, Pazos A. Dopamine D1 and D2 receptors in progressive supranuclear palsy: an autoradiographic study. Annals of Neurology. 32: 703-7. PMID 1449252 DOI: 10.1002/Ana.410320516  0.793
1992 Pascual J, Grijalba B, García-Sevilla JA, Zarranz JJ, Pazos A. Loss of high-affinity alpha 2-adrenoceptors in Alzheimer's disease: an autoradiographic study in frontal cortex and hippocampus. Neuroscience Letters. 142: 36-40. PMID 1357610 DOI: 10.1016/0304-3940(92)90614-D  0.802
1992 Lafarga M, Berciano MT, Del Olmo E, Andres MA, Pazos A. Osmotic stimulation induces changes in the expression of beta-adrenergic receptors and nuclear volume of astrocytes in supraoptic nucleus of the rat. Brain Research. 588: 311-6. PMID 1327410 DOI: 10.1016/0006-8993(92)91592-3  0.62
1992 Pascual J, del Arco C, González AM, Pazos A. Quantitative light microscopic autoradiographic localization of alpha 2-adrenoceptors in the human brain. Brain Research. 585: 116-27. PMID 1324768 DOI: 10.1016/0006-8993(92)91196-L  0.668
1991 Pascual J, Pazos A, del Olmo E, Figols J, Leno C, Berciano J. Presynaptic parkinsonism in olivopontocerebellar atrophy: clinical, pathological, and neurochemical evidence. Annals of Neurology. 30: 425-8. PMID 1952831 DOI: 10.1002/ana.410300318  0.619
1991 Pascual J, Fontán A, Zarranz JJ, Berciano J, Flórez J, Pazos A. High-affinity choline uptake carrier in Alzheimer's disease: implications for the cholinergic hypothesis of dementia. Brain Research. 552: 170-4. PMID 1913175 DOI: 10.1016/0006-8993(91)90676-M  0.544
1991 Pascual J, Gonzalez AM, Pazos A. Further studies on the biochemical characterization and autoradiographic distribution of [3H]hemicholinium-3 binding sites in rat brain: a presynaptic cholinergic marker. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 24: 345-55. PMID 1805188 DOI: 10.1016/1043-6618(91)90039-Z  0.578
1991 Pascual J, del Arco C, González AM, Díaz A, del Olmo E, Pazos A. Regionally specific age-dependent decline in alpha 2-adrenoceptors: an autoradiographic study in human brain. Neuroscience Letters. 133: 279-83. PMID 1687760 DOI: 10.1016/0304-3940(91)90588-K  0.757
1990 Pascual J, González AM, Pazos A. Characterization of [3H]hemicholinium-3 binding sites in human brain membranes: a marker for presynaptic cholinergic nerve terminals. Journal of Neurochemistry. 54: 792-800. PMID 2303811 DOI: 10.1111/J.1471-4159.1990.Tb02321.X  0.647
1990 Flórez J, del Arco C, González A, Pascual J, Pazos A. Autoradiographic studies of neurotransmitter receptors in the brain of newborn infants with Down syndrome. American Journal of Medical Genetics. Supplement. 7: 301-5. PMID 2149965 DOI: 10.1002/Ajmg.1320370759  0.659
1990 Fernández-López A, del Arco C, González AM, Gómez T, Calvo P, Pazos A. Autoradiographic localization of alpha 2-adrenoceptors in chick brain. Neuroscience Letters. 120: 97-100. PMID 1981385 DOI: 10.1016/0304-3940(90)90177-B  0.567
1990 Gonzalez AM, Pazos A. Autoradiographics patterns of modifications in brain muscarinic receptors following immobilization stress European Journal of Pharmacology. 183: 1401. DOI: 10.1016/0014-2999(90)94530-B  0.486
1990 Pazos A, Pascual J, Fontan A, Zarranz JJ, Florez J. Selective reduction in the cerebral activity of high affinity choline uptake in Alzheimer's disease European Journal of Pharmacology. 183: 938. DOI: 10.1016/0014-2999(90)92776-F  0.608
1989 Pascual J, González AM, Pazos A. Autoradiographic distribution of [3H]hemicholinium-3 binding sites in human brain. Brain Research. 505: 306-10. PMID 2598048 DOI: 10.1016/0006-8993(89)91457-1  0.644
1989 Cortés R, Gueye B, Pazos A, Probst A, Palacios JM. Dopamine receptors in human brain: autoradiographic distribution of D1 sites. Neuroscience. 28: 263-73. PMID 2522166 DOI: 10.1016/0306-4522(89)90178-4  0.56
1988 Cortés R, Soriano E, Pazos A, Probst A, Palacios JM. Autoradiography of antidepressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine. Neuroscience. 27: 473-96. PMID 2975361 DOI: 10.1016/0306-4522(88)90282-5  0.495
1988 Hoyer D, Waeber C, Pazos A, Probst A, Palacios JM. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites. Neuroscience Letters. 85: 357-62. PMID 2966310 DOI: 10.1016/0304-3940(88)90592-7  0.538
1988 Pazos A, González AM, Pascual J, Meana JJ, Barturen F, García-Sevilla JA. Alpha 2-adrenoceptors in human forebrain: autoradiographic visualization and biochemical parameters using the agonist [3H]UK-14304. Brain Research. 475: 361-5. PMID 2850839 DOI: 10.1016/0006-8993(88)90626-9  0.654
1988 Palacios JM, Pazos A, Dietl MM, Schlumpf M, Lichtensteiger W. The ontogeny of brain neurotensin receptors studied by autoradiography. Neuroscience. 25: 307-17. PMID 2839800  0.56
1987 Freund-Mercier MJ, Stoeckel ME, Palacios JM, Pazos A, Reichhart JM, Porte A, Richard P. Pharmacological characteristics and anatomical distribution of [3H]oxytocin-binding sites in the Wistar rat brain studied by autoradiography. Neuroscience. 20: 599-614. PMID 3647280 DOI: 10.1016/0306-4522(87)90113-8  0.491
1987 Pazos A, Probst A, Palacios JM. Serotonin receptors in the human brain--IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience. 21: 123-39. PMID 3601071 DOI: 10.1016/0306-4522(87)90327-7  0.598
1987 Pazos A, Probst A, Palacios JM. Serotonin receptors in the human brain--III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience. 21: 97-122. PMID 2955249  0.585
1987 Hoyer D, Vos P, Closse A, Pazos A, Palacios JM, Davies H. [3H]ketanserin labels 5-HT2 receptors and alpha 1-adrenoceptors in human and pig brain membranes. Naunyn-Schmiedeberg's Archives of Pharmacology. 335: 226-30. PMID 2884572 DOI: 10.1007/Bf00172788  0.601
1987 Fastbom J, Pazos A, Probst A, Palacios JM. Adenosine A1 receptors in the human brain: a quantitative autoradiographic study. Neuroscience. 22: 827-39. PMID 2825071 DOI: 10.1016/0306-4522(87)92962-9  0.578
1987 Fastbom J, Pazos A, Palacios JM. The distribution of adenosine A1 receptors and 5'-nucleotidase in the brain of some commonly used experimental animals. Neuroscience. 22: 813-26. PMID 2825070 DOI: 10.1016/0306-4522(87)92961-7  0.558
1987 Schlumpf M, Bruinink A, Lichtensteiger W, Cortés R, Palacios JM, Pazos A. Beta-adrenergic binding sites in fetal rat central nervous system and pineal gland: their relation to other receptor sites. Developmental Pharmacology and Therapeutics. 10: 422-35. PMID 2824144  0.497
1986 Hoyer D, Srivatsa S, Pazos A, Engel G, Palacios JM. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding. Neuroscience Letters. 69: 269-74. PMID 3763057 DOI: 10.1016/0304-3940(86)90492-1  0.508
1986 Pazos A, Wiederhold KH, Palacios JM. Central pressor effects induced by muscarinic receptor agonists: evidence for a predominant role of the M2 receptor subtype. European Journal of Pharmacology. 125: 63-70. PMID 3732392 DOI: 10.1016/0014-2999(86)90083-X  0.561
1986 Pazos A, Cymerman U, Probst A, Palacios JM. 'Peripheral' benzodiazepine binding sites in human brain and kidney: autoradiographic studies. Neuroscience Letters. 66: 147-52. PMID 3725180 DOI: 10.1016/0304-3940(86)90181-3  0.547
1986 Hoyer D, Pazos A, Probst A, Palacios JM. Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Research. 376: 85-96. PMID 3719375 DOI: 10.1016/0006-8993(86)90902-9  0.601
1986 Palacios JM, Markstein R, Pazos A. Serotonin-1C sites in the choroid plexus are not linked in a stimulatory or inhibitory way to adenylate cyclase. Brain Research. 380: 151-4. PMID 3019464 DOI: 10.1016/0006-8993(86)91439-3  0.555
1986 Cymerman U, Pazos A, Palacios JM. Evidence for species differences in 'peripheral' benzodiazepine receptors: an autoradiographic study. Neuroscience Letters. 66: 153-8. PMID 3014385  0.506
1986 Fastbom J, Pazos A, Probst A, Palacios JM. Adenosine A1-receptors in human brain: characterization and autoradiographic visualization. Neuroscience Letters. 65: 127-32. PMID 3012415 DOI: 10.1016/0304-3940(86)90291-0  0.607
1986 Hoyer D, Pazos A, Probst A, Palacios JM. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Research. 376: 97-107. PMID 2941113 DOI: 10.1016/0006-8993(86)90903-0  0.581
1985 Pazos A, Cortés R, Palacios JM. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Research. 346: 231-49. PMID 4052777  0.571
1985 Pazos A, Palacios JM. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Research. 346: 205-30. PMID 4052776 DOI: 10.1016/0006-8993(85)90856-X  0.56
1985 Pazos A, Probst A, Palacios JM. Beta-adrenoceptor subtypes in the human brain: autoradiographic localization. Brain Research. 358: 324-8. PMID 3000516 DOI: 10.1016/0006-8993(85)90977-1  0.504
1985 Pazos A, Cortés R, Palacios JM. Thyrotropin-releasing hormone receptor binding sites: autoradiographic distribution in the rat and guinea pig brain. Journal of Neurochemistry. 45: 1448-63. PMID 2995586 DOI: 10.1111/J.1471-4159.1985.Tb07212.X  0.577
1985 Pazos A, Stoeckel ME, Hindelang C, Palacios JM. Autoradiographic studies on dopamine D2 receptors in rat pituitary: influence of hormonal states. Neuroscience Letters. 59: 1-7. PMID 2931628 DOI: 10.1016/0304-3940(85)90206-X  0.489
1985 Pazos A, Engel G, Palacios JM. beta-Adrenoceptor blocking agents recognize a subpopulation of serotonin receptors in brain. Brain Research. 343: 403-8. PMID 2864978 DOI: 10.1016/0006-8993(85)90766-8  0.594
1984 Pazos A, Hoyer D, Palacios JM. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. European Journal of Pharmacology. 106: 539-46. PMID 6519175 DOI: 10.1016/0014-2999(84)90057-8  0.484
1984 Pazos A, Hoyer D, Palacios JM. Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. European Journal of Pharmacology. 106: 531-8. PMID 6519174 DOI: 10.1016/0014-2999(84)90056-6  0.619
1984 Pazos A, Flórez J. A comparative study in rats of the respiratory depression and analgesia induced by mu- and delta-opioid agonists. European Journal of Pharmacology. 99: 15-21. PMID 6373310 DOI: 10.1016/0014-2999(84)90427-8  0.334
1984 Pazos A, Cortés R, Palacios JM. Quantitative receptor autoradiography: application to the characterization of multiple receptor subtypes. Journal of Receptor Research. 4: 645-56. PMID 6241253  0.382
1983 Pazos A, Flórez J. Interaction of naloxone with mu- and delta-opioid agonists on the respiration of rats. European Journal of Pharmacology. 87: 309-14. PMID 6301857 DOI: 10.1016/0014-2999(83)90343-6  0.312
1982 Pazos A, Mediavilla A, Flórez J. Cardiovascular effects of intracerebroventricular injection of dopamine after selective MAO inhibition in rats. Neuropharmacology. 21: 317-22. PMID 6283412 DOI: 10.1016/0028-3908(82)90094-6  0.307
1980 Flórez J, Mediavilla A, Pazos A. Respiratory effects of beta-endorphin, D-Ala2-met-enkephalinamide, and Met-enkephalin injected into the lateral ventricle and the pontomedullary subarachnoid space. Brain Research. 199: 197-206. PMID 7407621 DOI: 10.1016/0006-8993(80)90240-1  0.315
Show low-probability matches.